scholarly article | Q13442814 |
P50 | author | David H. O’Connor | Q28321062 |
Miranda Z. Smith | Q38359495 | ||
Jason Weinfurter | Q38359514 | ||
Robert De Rose | Q38359536 | ||
Andrew G Brooks | Q38359557 | ||
Stephen J. Kent | Q38359577 | ||
David I Watkins | Q66732113 | ||
P2093 | author name string | Ivan Stratov | |
Kendall Krebs | |||
Caroline S Fernandez | |||
C Jane Dale | |||
Cara Riek | |||
P2860 | cites work | HLA-B typing by reference strand mediated conformation analysis using a capillary-based semiautomated genetic analyzer | Q73734467 |
A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing | Q74150972 | ||
High resolution HLA class I typing by reference strand mediated conformation analysis (RSCA) | Q77134786 | ||
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 | ||
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution | Q27660465 | ||
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus | Q28302762 | ||
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus | Q33786257 | ||
Houdini's box: towards an understanding of AIDS virus escape from the cytotoxic T-lymphocyte response | Q33797461 | ||
Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost | Q33813173 | ||
Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys | Q33815102 | ||
CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing | Q33835440 | ||
Vaccination with attenuated simian immunodeficiency virus by DNA inoculation | Q33850355 | ||
Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques | Q33850605 | ||
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys | Q33850904 | ||
Cellular immune responses to HIV. | Q34223069 | ||
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency | Q34326613 | ||
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection | Q34348640 | ||
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection | Q34353799 | ||
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection | Q34358162 | ||
Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection | Q34361731 | ||
Species-specific evolution of MHC class I genes in the higher primates | Q34487697 | ||
Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys | Q35149425 | ||
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. | Q36368095 | ||
Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex | Q36400759 | ||
Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge | Q36538907 | ||
The MHC class I genes of the rhesus monkey. Different evolutionary histories of MHC class I and II genes in primates. | Q36800931 | ||
Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. | Q36831093 | ||
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities | Q36954486 | ||
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. | Q38318792 | ||
Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease | Q38456639 | ||
CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV). | Q38942811 | ||
Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens | Q39548957 | ||
Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus- mycobacterium coinfection | Q39653781 | ||
Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens | Q39683959 | ||
Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses | Q39796603 | ||
Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation. | Q40569689 | ||
The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon | Q41634806 | ||
Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys | Q41677732 | ||
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis | Q42802250 | ||
Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge | Q43830379 | ||
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. | Q44022556 | ||
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection | Q44519261 | ||
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry | Q45112956 | ||
Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I. | Q45158601 | ||
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans | Q45723463 | ||
Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity | Q45729365 | ||
Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques | Q45730586 | ||
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity | Q45734062 | ||
Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology | Q45743923 | ||
Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. | Q45755361 | ||
Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity | Q45860301 | ||
Characterization of pig-tailed macaque classical MHC class I genes: implications for MHC evolution and antigen presentation in macaques | Q48237545 | ||
Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. | Q53781127 | ||
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA | Q56930699 | ||
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes | Q57075675 | ||
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia | Q57075698 | ||
The use of reference strand-mediated conformational analysis for the study of cheetah (Acinonyx jubatus) feline leucocyte antigen class II DRB polymorphisms | Q57216045 | ||
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS | Q73034306 | ||
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination | Q73097737 | ||
Six mamu-A locus alleles defined by a polymerase chain reaction sequence specific primer method | Q73200142 | ||
AIDS research. Vaccine studies stymied by shortage of animals | Q73485448 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Macaca | Q177601 |
Simian immunodeficiency virus | Q1890246 | ||
P304 | page(s) | 684-695 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes | |
P478 | volume | 79 |